Abstract
Fibroblasts play a major role in normal cardiac physiology and in the response of the heart to injury and disease. Cardiac electrophysiological research has primarily focused on the mechanisms of remodeling that accompany cardiac disease with an emphasis on myocyte electrophysiology. Recently, there has been increasing interest in the potential role of fibroblasts in cardiac electrophysiology. This review focuses on the arrhythmia mechanisms involving interactions between myocytes and fibroblasts. We also discuss the available evidence supporting the contribution of intracardiac and extracardiac sources to the fibroblast and myofibroblast populations in diseased hearts.
Similar content being viewed by others
References
Roger, V. L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., et al. Heart disease and stroke statistics 2012 update. Circulation. doi:10.1161/CIR.0b013e31823ac046.
Rohr, S. (2012). Arrhythmogenic implications of fibroblast–myocyte interactions. Circulation. Arrhythmia and Electrophysiology, 5(2), 442–452. doi:10.1161/CIRCEP.110.957647.
Rosker, C., Salvarani, N., Schmutz, S., Grand, T., & Rohr, S. (2011). Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of alpha-smooth muscle actin containing stress fibers. Circulation Research, 109(10), 1120–1131. doi:10.1161/CIRCRESAHA.111.244798.
Rohr, S. (2009). Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm, 6(6), 848–856. doi:10.1016/j.hrthm.2009.02.038.
Miragoli, M., Salvarani, N., & Rohr, S. (2007). Myofibroblasts induce ectopic activity in cardiac tissue. Circulation Research, 101(8), 755–758. doi:10.1161/CIRCRESAHA.107.160549.
Miragoli, M., Gaudesius, G., & Rohr, S. (2006). Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circulation Research, 98(6), 801–810. doi:10.1161/01.RES.0000214537.44195.a3.
Gaudesius, G., Miragoli, M., Thomas, S. P., & Rohr, S. (2003). Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circulation Research, 93(5), 421–428. doi:10.1161/01.RES.0000089258.40661.0C.
Vasquez, C., Mohandas, P., Louie, K. L., Benamer, N., Bapat, A. C., & Morley, G. E. (2010). Enhanced fibroblast–myocyte interactions in response to cardiac injury. Circulation Research, 107(8), 1011–1020. doi:10.1161/CIRCRESAHA.110.227421.
McSpadden, L. C., Nguyen, H., & Bursac, N. (2012). Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs. Circulation. Arrhythmia and Electrophysiology. doi:10.1161/CIRCEP.111.969329.
Pedrotty, D. M., Klinger, R. Y., Kirkton, R. D., & Bursac, N. (2009). Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovascular Research, 83(4), 688–697. doi:10.1093/cvr/cvp164.
Zlochiver, S., Munoz, V., Vikstrom, K. L., Taffet, S. M., Berenfeld, O., & Jalife, J. (2008). Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophysical Journal, 95(9), 4469–4480. doi:10.1529/biophysj.108.136473.
Nguyen, T. P., Xie, Y., Garfinkel, A., Qu, Z., & Weiss, J. N. (2012). Arrhythmogenic consequences of myofibroblast–myocyte coupling. Cardiovascular Research, 93(2), 242–251. doi:10.1093/cvr/cvr292.
Xie, Y., Garfinkel, A., Weiss, J. N., & Qu, Z. (2009). Cardiac alternans induced by fibroblast–myocyte coupling: mechanistic insights from computational models. American Journal of Physiology - Heart and Circulatory Physiology, 297(2), H775–H784. doi:10.1152/ajpheart.00341.2009.
Xie, Y., Garfinkel, A., Camelliti, P., Kohl, P., Weiss, J. N., & Qu, Z. (2009). Effects of fibroblast–myocyte coupling on cardiac conduction and vulnerability to reentry: a computational study. Heart Rhythm, 6(11), 1641–1649. doi:10.1016/j.hrthm.2009.08.003.
Jacquemet, V., & Henriquez, C. S. (2009). Modulation of conduction velocity by nonmyocytes in the low coupling regime. IEEE Transactions on Biomedical Engineering, 56(3), 893–896. doi:10.1109/TBME.2008.2006028.
Jacquemet, V., & Henriquez, C. S. (2008). Loading effect of fibroblast–myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model. American Journal of Physiology - Heart and Circulatory Physiology, 294(5), H2040–H2052. doi:10.1152/ajpheart.01298.2007.
Jacquemet, V., & Henriquez, C. S. (2007). Modelling cardiac fibroblasts: interactions with myocytes and their impact on impulse propagation. Europace, 9(Suppl 6), vi29–vi37. doi:10.1093/europace/eum207.
Nag, A. C. (1980). Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios, 28(109), 41–61.
Zak, R. (1974). Development and proliferative capacity of cardiac muscle cells. Circulation Research, 35((2) suppl II), 17–26.
Banerjee, I., Fuseler, J. W., Price, R. L., Borg, T. K., & Baudino, T. A. (2007). Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. American Journal of Physiology—Heart and Circulatory Physiology, 293(3), H1883–H1891. doi:10.1152/ajpheart.00514.2007.
Zeisberg, E. M., & Kalluri, R. (2010). Origins of cardiac fibroblasts. Circulation Research, 107(11), 1304–1312. doi:10.1161/CIRCRESAHA.110.231910.
Yano, T., Miura, T., Ikeda, Y., Matsuda, E., Saito, K., Miki, T., et al. (2005). Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovascular Pathology, 14(5), 241–246. doi:10.1016/j.carpath.2005.05.004.
Kania, G., Blyszczuk, P., Stein, S., Valaperti, A., Germano, D., Dirnhofer, S., et al. (2009). Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circulation Research, 105(5), 462–470. doi:10.1161/CIRCRESAHA.109.196287.
Mollmann, H., Nef, H. M., Kostin, S., von Kalle, C., Pilz, I., Weber, M., et al. (2006). Bone marrow-derived cells contribute to infarct remodelling. Cardiovascular Research, 71(4), 661–671. doi:10.1016/j.cardiores.2006.06.013.
Odorfer, K. I., Walter, I., Kleiter, M., Sandgren, E. P., & Erben, R. G. (2008). Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction. Journal of Cellular and Molecular Medicine, 12(6B), 2867–2874. doi:10.1111/j.1582-4934.2008.00511.x.
Pichler, M., Rainer, P. P., Schauer, S., & Hoefler, G. (2012). Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. Journal of the American College of Cardiology, 59(11), 1008–1016. doi:10.1016/j.jacc.2011.11.036.
Sato, D., Otani, H., Enoki, C., Fujita, M., Minato, N., & Iwasaka, T. (2011). Phenotypic modulation and turnover of bone marrow-derived cells after myocardial infarction in rats. Cardiovascular Pathology, 20(3), 146–155. doi:10.1016/j.carpath.2010.04.001.
van Amerongen, M. J., Bou-Gharios, G., Popa, E., van Ark, J., Petersen, A. H., van Dam, G. M., et al. (2008). Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. The Journal of Pathology, 214(3), 377–386. doi:10.1002/path.2281.
Wu, G. D., Tuan, T. L., Bowdish, M. E., Jin, Y. S., Starnes, V. A., Cramer, D. V., et al. (2003). Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Transplantation, 76(3), 609–614. doi:10.1097/01.TP.0000066362.37931.6D.
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., et al. (2006). Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proceedings of the National Academy of Sciences of the United States of America, 103(48), 18284–18289. doi:10.1073/pnas.0608799103.
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13(8), 952–961. doi:10.1038/nm1613.
Aisagbonhi, O., Rai, M., Ryzhov, S., Atria, N., Feoktistov, I., & Hatzopoulos, A. K. (2011). Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Disease Models & Mechanisms, 4(4), 469–483. doi:10.1242/dmm.006510.
Alva, J. A., Zovein, A. C., Monvoisin, A., Murphy, T., Salazar, A., Harvey, N. L., et al. (2006). VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Developmental Dynamics, 235(3), 759–767. doi:10.1002/dvdy.20643.
Chu, P. Y., Mariani, J., Finch, S., McMullen, J. R., Sadoshima, J., Marshall, T., et al. (2010). Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. American Journal of Pathology, 176(4), 1735–1742. doi:10.2353/ajpath.2010.090574.
Duan, J., Gherghe, C., Liu, D., Hamlett, E., Srikantha, L., Rodgers, L., et al. (2012). Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO Journal, 31(2), 429–442. doi:10.1038/emboj.2011.418.
Hocht-Zeisberg, E., Kahnert, H., Guan, K., Wulf, G., Hemmerlein, B., Schlott, T., et al. (2004). Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. European Heart Journal, 25(9), 749–758. doi:10.1016/j.ehj.2004.01.017.
Okayama, K., Azuma, J., Dosaka, N., Iekushi, K., Sanada, F., Kusunoki, H., et al. (2012). Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial–mesenchymal transition. Hypertension, 59(5), 958–965. doi:10.1161/HYPERTENSIONAHA.111.183905.
Szardien, S., Nef, H. M., Troidl, C., Willmer, M., Voss, S., Liebetrau, C., et al. (2012). Bone marrow-derived cells contribute to cell turnover in aging murine hearts. International Journal of Molecular Medicine, 30(2), 283–287. doi:10.3892/ijmm.2012.995.
van Tuyn, J., Atsma, D. E., Winter, E. M., van der Velde-van, D. I., Pijnappels, D. A., Bax, N. A., et al. (2007). Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells, 25(2), 271–278. doi:10.1634/stemcells.2006-0366.
Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D. W., Adiarto, S., Iwasa, N., et al. (2010). Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation, 121(22), 2407–2418. doi:10.1161/CIRCULATIONAHA.110.938217.
Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J. H., Butterfield, C., et al. (2011). Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. Journal of Clinical Investigation, 121(5), 1894–1904. doi:10.1172/JCI45529.
Zhou, B., & Pu, W. T. (2011). Epicardial epithelial-to-mesenchymal transition in injured heart. Journal of Cellular and Molecular Medicine, 15(12), 2781–2783. doi:10.1111/j.1582-4934.2011.01450.x.
Fries, K. M., Blieden, T., Looney, R. J., Sempowski, G. D., Silvera, M. R., Willis, R. A., et al. (1994). Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clinical Immunology and Immunopathology, 72(3), 283–292.
Lekic, P. C., Pender, N., & McCulloch, C. A. (1997). Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Critical Reviews in Oral Biology and Medicine, 8(3), 253–268.
Chang, H. Y., Chi, J. T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., et al. (2002). Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 99(20), 12877–12882. doi:10.1073/pnas.162488599.
Burstein, B., Libby, E., Calderone, A., & Nattel, S. (2008). Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation, 117(13), 1630–1641. doi:10.1161/CIRCULATIONAHA.107.748053.
Flack, E. C., Lindsey, M. L., Squires, C. E., Kaplan, B. S., Stroud, R. E., Clark, L. L., et al. (2006). Alterations in cultured myocardial fibroblast function following the development of left ventricular failure. Journal of Molecular and Cellular Cardiology, 40(4), 474–483. doi:10.1016/j.yjmcc.2006.01.019.
Squires, C. E., Escobar, G. P., Payne, J. F., Leonardi, R. A., Goshorn, D. K., Sheats, N. J., et al. (2005). Altered fibroblast function following myocardial infarction. Journal of Molecular and Cellular Cardiology, 39(4), 699–707. doi:10.1016/j.yjmcc.2005.07.008.
Jarvis, M. D., Rademaker, M. T., Ellmers, L. J., Currie, M. J., McKenzie, J. L., Palmer, B. R., et al. (2006). Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles. American Journal of Physiology—Heart and Circulatory Physiology, 291(4), H1952–H1958. doi:10.1152/ajpheart.00764.2005.
Vasquez, C., Benamer, N., & Morley, G. E. (2011). The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. Journal of Cardiovascular Pharmacology, 57(4), 380–388. doi:10.1097/FJC.0b013e31820cda19.
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005). The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annual Review of Pharmacology and Toxicology, 45, 657–687. doi:10.1146/annurev.pharmtox.45.120403.095802.
Desmouliere, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. The Journal of Cell Biology, 122(1), 103–111.
Sappino, A. P., Schurch, W., & Gabbiani, G. (1990). Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Laboratory Investigation, 63(2), 144–161.
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999). Myofibroblasts. I. Paracrine cells important in health and disease. American Journal of Physiology, 277(1 Pt 1), C1–C9.
Petrov, V. V., Fagard, R. H., & Lijnen, P. J. (2002). Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension, 39(2), 258–263.
Kondalenko, V. G., Babaev, V. R., & Rukosuev, V. S. (1981). Myofibroblasts in a zone of myocardial infarction. Bulletin of Experimental Biology and Medicine, 92(6), 1727–1729. doi:10.1007/bf00837725.
Vracko, R., & Thorning, D. (1993). Myofibroblasts and smooth muscle cells in human myocardial scars: possible origins and inductive factors. Cardiovascular Pathology, 2(3), 207–213.
Eyden, B. (2005). The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 1—normal and reactive cells. Journal of Submicroscopic Cytology and Pathology, 37(2), 109–204.
Sun, Y., Kiani, M. F., Postlethwaite, A. E., & Weber, K. T. (2002). Infarct scar as living tissue. Basic Research in Cardiology, 97(5), 343–347. doi:10.1007/s00395-002-0365-8.
Lu, D., Soleymani, S., Madakshire, R., & Insel, P. A. (2012). ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors. The FASEB Journal, 26(6), 2580–2591. doi:10.1096/fj.12-204677.
Sun, Y., & Weber, K. T. (2000). Infarct scar: a dynamic tissue. Cardiovascular Research, 46(2), 250–256.
Willems, I. E., Havenith, M. G., De Mey, J. G., & Daemen, M. J. (1994). The alpha-smooth muscle actin-positive cells in healing human myocardial scars. American Journal of Pathology, 145(4), 868–875.
Jugdutt, B. I. (2003). Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Current Drug Targets. Cardiovascular & Haematological Disorders, 3(1), 1–30.
Wessels, A., & Perez-Pomares, J. M. (2004). The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 276(1), 43–57. doi:10.1002/ar.a.10129.
Wessels, A., van den Hoff, M. J., Adamo, R. F., Phelps, A. L., Lockhart, M. M., Sauls, K., et al. (2012). Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Developmental Biology, 366(2), 111–124. doi:10.1016/j.ydbio.2012.04.020.
Mikawa, T., & Gourdie, R. G. (1996). Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Developmental Biology, 174(2), 221–232. doi:10.1006/dbio.1996.0068.
Perez-Pomares, J. M., Carmona, R., Gonzalez-Iriarte, M., Atencia, G., Wessels, A., & Munoz-Chapuli, R. (2002). Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. International Journal of Developmental Biology, 46(8), 1005–1013.
Lie-Venema, H., van den Akker, N. M., Bax, N. A., Winter, E. M., Maas, S., Kekarainen, T., et al. (2007). Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. The Scientific World Journal, 7, 1777–1798. doi:10.1100/tsw.2007.294.
Potts, J. D., & Runyan, R. B. (1989). Epithelial–mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Developmental Biology, 134(2), 392–401.
Norris, R. A., Borg, T. K., Butcher, J. T., Baudino, T. A., Banerjee, I., & Markwald, R. R. (2008). Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Annals of the New York Academy of Sciences, 1123, 30–40. doi:10.1196/annals.1420.005.
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011). Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. American Journal of Pathology, 179(3), 1074–1080. doi:10.1016/j.ajpath.2011.06.001.
Fredj, S., Bescond, J., Louault, C., & Potreau, D. (2005). Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. Journal of Cellular Physiology, 202(3), 891–899. doi:10.1002/jcp.20197.
Lucas, J.A., Zhang, Y., Li, P., Gong, K., Miller, A.P., Hassan, E., et al. Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. American Journal of Physiology—Heart and Circulatory Physiology, 298(2),H424–432. doi: 10.1152/ajpheart.00529.2009.
Eisenberg, L. M., & Markwald, R. R. (1995). Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circulation Research, 77(1), 1–6.
Ursell, P. C., Gardner, P. I., Albala, A., Fenoglio, J. J., Jr., & Wit, A. L. (1985). Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circulation Research, 56(3), 436–451.
Dillon, S. M., Allessie, M. A., Ursell, P. C., & Wit, A. L. (1988). Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circulation Research, 63, 182–206.
Gardner, P. I., Ursell, P. C., Fenoglio, J. J., Jr., & Wit, A. L. (1985). Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation, 72(3), 596–611.
Rook, M. B., Jongsma, H. J., & de Jonge, B. (1989). Single channel currents of homo- and heterologous gap junctions between cardiac fibroblasts and myocytes. Pflügers Archiv, 414(1), 95–98.
Rook, M. B., van Ginneken, A. C., de Jonge, B., el Aoumari, A., Gros, D., & Jongsma, H. J. (1992). Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. American Journal of Physiology, 263(5 Pt 1), C959–C977.
Fahrenbach, J. P., Mejia-Alvarez, R., & Banach, K. (2007). The relevance of non-excitable cells for cardiac pacemaker function. The Journal of Physiology, 585(Pt 2), 565–578. doi:10.1113/jphysiol.2007.144121.
Lafontant, P. J., Burns, A. R., Donnachie, E., Haudek, S. B., Smith, C. W., & Entman, M. L. (2006). Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts. American Journal of Physiology. Cell Physiology, 291(1), C18–C26. doi:10.1152/ajpcell.00322.2005.
Gray, M. O., Long, C. S., Kalinyak, J. E., Li, H. T., & Karliner, J. S. (1998). Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovascular Research, 40(2), 352–363.
Camelliti, P., Devlin, G. P., Matthews, K. G., Kohl, P., & Green, C. R. (2004). Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovascular Research, 62(2), 415–425. doi:10.1016/j.cardiores.2004.01.027.
Zhang, Y., Kanter, E. M., & Yamada, K. A. (2010). Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovascular Pathology, 19(6), E233–E240. doi:10.1016/j.carpath.2009.12.002.
Acknowledgments
This work was supported by a NIH grant to GEM (HL076751).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vasquez, C., Morley, G.E. The Origin and Arrhythmogenic Potential of Fibroblasts in Cardiac Disease. J. of Cardiovasc. Trans. Res. 5, 760–767 (2012). https://doi.org/10.1007/s12265-012-9408-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9408-1